Skip to main content
Fig. 11 | Cancer Cell International

Fig. 11

From: CD5L-associated gene analyses highlight the dysregulations, prognostic effects, immune associations, and drug-sensitivity predicative potentials of LCAT and CDC20 in hepatocellular carcinoma

Fig. 11

Comparisons of serum CD5L concentration and LCAT activity between HCC patients and normal controls. A There was no significant difference of serum CD5L concentration between HCC patients and normal controls. B The relative activity of LCAT was lower in HCC serum than normal serum. C ROC analysis of serum LCAT in discriminating HCC and normal controls. D Significant positive correlation between serum LCAT activity and HDL concentration in HCC. E No significant correlation between serum LCAT activity and AFP concentration in HCC. F Significant positive correlation between serum LCAT activity and ALB concentration in HCC. Wilcoxon test, ROC analysis, and Spearman correlation analysis were used and p < 0.05 was considered significant

Back to article page